These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17008193)

  • 1. Population effectiveness of pharmaceutical aids for smoking cessation: what is associated with increased success?
    Gilpin EA; Messer K; Pierce JP
    Nicotine Tob Res; 2006 Oct; 8(5):661-9. PubMed ID: 17008193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aids to quitting tobacco use: how important are they outside controlled trials?
    Solberg LI; Boyle RG; Davidson G; Magnan S; Link Carlson C; Alesci NL
    Prev Med; 2001 Jul; 33(1):53-8. PubMed ID: 11482996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation.
    Pierce JP; Gilpin EA
    JAMA; 2002 Sep; 288(10):1260-4. PubMed ID: 12215133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY; Lim SS; Wallace AL; Vos T
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of smoke-free homes on smoking behavior in the U.S.
    Messer K; Mills AL; White MM; Pierce JP
    Am J Prev Med; 2008 Sep; 35(3):210-6. PubMed ID: 18620837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking cessation treatment in a real-life setting: the Greek experience.
    Rovina N; Nikoloutsou I; Dima E; Michailidou M; Roussos C; Gratziou C
    Ther Adv Respir Dis; 2007 Dec; 1(2):93-104. PubMed ID: 19124351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation.
    Marlow SP; Stoller JK
    Respir Care; 2003 Dec; 48(12):1238-54; discussion 1254-6. PubMed ID: 14651764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales.
    McEwen A; West R; Owen L
    Addiction; 2004 Nov; 99(11):1470-4. PubMed ID: 15500600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glucose on tobacco withdrawal symptoms in recent quitters using bupropion or nicotine replacement.
    McRobbie H; Hajek P
    Hum Psychopharmacol; 2004 Jan; 19(1):57-61. PubMed ID: 14716714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors associated with abstinence in a smoking cessation program].
    Tamblay N; Seijas D
    Rev Med Chil; 2008 Feb; 136(2):179-85. PubMed ID: 18483671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking status of Australian general practice patients and their attempts to quit.
    Doran CM; Valenti L; Robinson M; Britt H; Mattick RP
    Addict Behav; 2006 May; 31(5):758-66. PubMed ID: 16137834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies.
    Vogt F; Hall S; Marteau TM
    Nicotine Tob Res; 2008 Aug; 10(8):1405-13. PubMed ID: 18686189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of over-the-counter sales of the nicotine patch and nicotine gum on smoking cessation in California.
    Reed MB; Anderson CM; Vaughn JW; Burns DM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2131-6. PubMed ID: 16172221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
    Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
    Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pragmatic, observational study of bupropion treatment for smoking cessation in general practice.
    Wilkes S; Evans A; Henderson M; Gibson J
    Postgrad Med J; 2005 Nov; 81(961):719-22. PubMed ID: 16272237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploration of Latino smokers and the use of pharmaceutical aids.
    Levinson AH; Borrayo EA; Espinoza P; Flores ET; Pérez-Stable EJ
    Am J Prev Med; 2006 Aug; 31(2):167-71. PubMed ID: 16829334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What can we do in secondary prevention of cigarette smoking?
    Haustein KO
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):476-85. PubMed ID: 14671472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General practitioners' beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies.
    Vogt F; Hall S; Marteau TM
    BMC Public Health; 2006 Nov; 6():277. PubMed ID: 17092346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.